Study on the Safety and Efficacy of Meplazumab for Injection in Severe Patients With COVID-19

NCT05679479 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

108

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

BIOLOGICAL: Meplazumab for injection
OTHER: Normal saline

Sponsor

Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd